HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Employees - 21,
CEO - Mr. Robert P. Eno,
Sector - Healthcare,
Country - US,
Market Cap - 70.82M
Altman ZScore(max is 10): -24.84, Piotroski Score(max is 10): 1, Working Capital: $1148000, Total Assets: $3276000, Retained Earnings: $-56273000, EBIT: -24977000, Total Liabilities: $1622000, Revenue: $0
AryaFin Target Price - $0.08 - Current Price $2.10 - Analyst Target Price $5.00
| Ticker | BEAT |
| Index | - |
| Curent Price | 2.10 |
| Change | 9.37% |
| Market Cap | 70.82M |
| Average Volume | 87.41K |
| Income | -19.45M |
| Sales | 0.00M |
| Book Value/Share | 0.06 |
| Cash/Share | 0.07 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 21 |
| Moving Avg 20days | 20.02% |
| Moving Avg 50days | 8.79% |
| Moving Avg 200days | -8.33% |
| Shares Outstanding | 26.96M |
| Earnings Date | Mar 13 AMC |
| Inst. Ownership | 7.89% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | - |
| Price/Book | 34.23 |
| Price/Cash | 29.76 |
| Price/FCF | - |
| Quick Ratio | 1.71 |
| Current Ratio | 1.71 |
| Debt/Equity | 0.00 |
| Return on Assets | -190.60% |
| Return on Equity | -221.11% |
| Return on Investment | -1175.82% |
| Gross Margin | - |
| Ops Margin | - |
| Profit Margin | - |
| RSI | 64.96 |
| BETA(β) | -0.58 |
| From 52week Low | 44.83% |
| From 52week High | -39.66% |
| EPS | -0.73 |
| EPS next Year | -0.69 |
| EPS next Qtr | -0.15 |
| EPS this Year | 28.08% |
| EPS next 5 Year | 42.33% |
| EPS past 5 Year | -61.91% |
| Sales past 5 Year | 0.00% |
| EPS Y/Y | 22.50% |
| Sales Y/Y | - |
| EPS Q/Q | -24.51% |
| Sales Q/Q | - |
| Sales Surprise | - |
| EPS Surprise | 5.26% |
| ATR(14) | 0.15 |
| Perf Week | 29.25% |
| Perf Month | 8.25% |
| Perf Quarter | -0.94% |
| Perf Year | 2.94% |
| Perf YTD | -8.70% |
| Target Price | 5.00 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer